Compare studies and check their requirements with the research team.
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression for depression in bipolarity.
In United StatesThis study is completed in the United States. It is testing EVP-6124 for schizophrenia.
In United StatesThis study is suspended in the United States. It is testing APN1125 for schizophrenia.
In United States
This study is completed in the United States. It focuses on Addiction.
In United StatesThis study is completed in the United States. It is testing iloperidone Depot for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing lumateperone for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Lumateperone Long-Acting Injectable Formulations for schizophrenia.
In United StatesThis study was terminated in the United States. It is testing Multiple Rising Doses of TAK-137 for ADHD.
In United StatesThis study is completed in the United States. It is testing OMS643762 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Single Doses of APN1125 for Schizophrenia.
In United StatesThis study is completed in the United States. It focuses on Schizophrenia.
In United StatesThis study is completed in the United States. It is testing elpipodect for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.